Ralmitaront (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name; developmental code names RG-7906 and RO-6889450) is an investigational antipsychotic drug which is undergoing a clinical trial for the treatment of negative symptoms in schizophrenia and schizoaffective disorder.

[1][2][3] Another clinical trial targeting acute psychotic symptoms of schizophrenia has been terminated due to lack of efficacy.

[5] The medication is being developed by the pharmaceutical company Hoffmann-La Roche.

[1] Ralmitaront had completed phase 1 clinical trials.

This drug article relating to the nervous system is a stub.